Startups
2021
IVESTATIN THERAPEUTICS SLReducing the deleterious effects of ACS (Acute Coronary Syndrome)
International leader in providing innovative solutions in the field of ischemic damage, ensuring excellent results for our customers and delivering value to shareholders.
International leader in providing innovative solutions in the field of ischemic damage, ensuring excellent results for our customers and delivering value to shareholders.
Address
Carretera de Collblanc 154, 08028 Barcelona, Spain
CERCA ownership
Barcelona, Spain
1992
Institut de Recerca Sant Pau
Status & Deeptech areas
Company Status & Company Deeptech AreasCurrent company status
DeepTech Area
Spinoff information
Company Description
To become a worldwide solution for reducing the ischemic damage after an acute myocardial infarction (AMI), ischemic stroke or transplanted organ by providing an innovative and breakthrough treatment through a process of innovation, research and development, driven by a desire to improve the quality of patients’ lives.